 |
Prescription and Over-the-Counter Drug Product List - 21st Edition
Cumulative Supplement Number 9: January-September 2001
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section CUMULATIVE SUPPLEMENT LEGEND.
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>D> ENDO PHARMS 400MG;5MG N40288 001 NOV 27, 1998 SEP CTEC
>D> 400MG;7.5MG N40288 002 NOV 27, 1998 SEP CTEC
>D> 400MG;10MG N40288 003 NOV 27, 1998 SEP CTEC
>A> + 400MG;5MG N40288 001 NOV 27, 1998 SEP CTEC
>A> + 400MG;10MG N40288 003 NOV 27, 1998 SEP CTEC
>A> + 400MG;7.5MG N40288 002 NOV 27, 1998 SEP CTEC
ALPRAZOLAM
SOLUTION; ORAL
ALPRAZOLAM
>D> + ROXANE 0.5MG/5ML N74314 001 OCT 31, 1993 SEP DISC
>A> @ 0.5MG/5ML N74314 001 OCT 31, 1993 SEP DISC
AMLEXANOX
PASTE; DENTAL
APHTHASOL
>D> + BLOCK DRUG 5% N20511 001 DEC 17, 1996 SEP CAHN
>A> + GLAXOSMITHKLINE CONS 5% N20511 001 DEC 17, 1996 SEP CAHN
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID;
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE
HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION
MVC PLUS
>D> AP + STERIS 10MG/ML;0.006MG/ML;0.5UGM/
ML;1.5MG/ML;20
IU/ML;0.04MG/ML;4MG/ML;0.4
MG/ML;0.36MG/ML;0.3MG/ML;3
30 UNITS/ML;1 IU/ML N18439 002 AUG 08, 1985 SEP DISC
>A> @ 10MG/ML;0.006MG/ML;0.5UGM/
ML;1.5MG/ML;20
IU/ML;0.04MG/ML;4MG/ML;0.4
MG/ML;0.36MG/ML;0.3MG/ML;3
30 UNITS/ML;1 IU/ML N18439 002 AUG 08, 1985 SEP DISC
BUTOCONAZOLE NITRATE
CREAM; VAGINAL
GYNAZOLE-1
>D> + KV PHARM 2% N19881 001 FEB 07, 1997 SEP CTNA
>A> + 2% N19881 001 FEB 07, 1997 SEP CTNA
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>A> AP HIKMA EQ 500MG BASE/VIAL N65047 001 SEP 18, 2001 SEP NEWA
>A> AP EQ 1GM BASE/VIAL N65047 002 SEP 18, 2001 SEP NEWA
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CHLORPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HCL
>D> AB GENEVA PHARMS 12MG;75MG N88940 001 JAN 26, 1989 SEP DISC
>A> @ 12MG;75MG N88940 001 JAN 26, 1989 SEP DISC
DRIZE
>D> BC ASCHER 12MG;75MG N88359 001 FEB 13, 1986 SEP DISC
>A> @ 12MG;75MG N88359 001 FEB 13, 1986 SEP DISC
ORNADE
>D> AB + SMITHKLINE BEECHAM 12MG;75MG N12152 004 JAN 06, 1981 SEP DISC
>A> @ 12MG;75MG N12152 004 JAN 06, 1981 SEP DISC
CLINDAMYCIN PHOSPHATE
GEL; TOPICAL
CLINDAMYCIN PHOSPHATE
>A> BT GALDERMA LABS LP EQ 1% BASE N50782 001 NOV 27, 2000 SEP CAHN
>D> BT TARGET RES EQ 1% BASE N50782 001 NOV 27, 2000 SEP CAHN
CLONIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
DURACLON
>A> + ELAN PHARMS 0.1MG/ML N20615 001 OCT 02, 1996 SEP CAHN
>D> + ROXANE 0.1MG/ML N20615 001 OCT 02, 1996 SEP CAHN
CROMOLYN SODIUM
AEROSOL, METERED; INHALATION
INTAL
>A> + AVENTIS 0.8MG/INH N18887 001 DEC 05, 1985 SEP CAHN
>D> + AVENTIS PHARMS 0.8MG/INH N18887 001 DEC 05, 1985 SEP CAHN
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL
>A> ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
>A> AB EON 5MG;12.5MG N76116 001 SEP 19, 2001 SEP NEWA
>A> AB 10MG;25MG N76116 002 SEP 19, 2001 SEP NEWA
>A> AB MYLAN 5MG;12.5MG N75624 001 SEP 18, 2001 SEP NEWA
>A> AB 10MG;25MG N75624 002 SEP 18, 2001 SEP NEWA
>A> AB TARO PHARM INDS 5MG;12.5MG N75788 001 SEP 18, 2001 SEP NEWA
>A> AB 10MG;25MG N75788 002 SEP 18, 2001 SEP NEWA
>A> AB TEVA 5MG;12.5MG N75727 001 SEP 18, 2001 SEP NEWA
>A> AB 10MG;25MG N75727 002 SEP 18, 2001 SEP NEWA
>A> VASERETIC
>D> MERCK 5MG;12.5MG N19221 003 JUL 12, 1995 SEP CFTG
>D> + 10MG;25MG N19221 001 OCT 31, 1986 SEP CFTG
>A> AB MERCK RES LABS 5MG;12.5MG N19221 003 JUL 12, 1995 SEP CFTG
>A> AB + 10MG;25MG N19221 001 OCT 31, 1986 SEP CFTG
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
DURANEST
>A> @ ASTRAZENECA 0.005MG/ML;1.5% N17751 007 AUG 30, 1976 SEP DISC
>D> + DENTSPLY PHARM 0.005MG/ML;1.5% N17751 007 AUG 30, 1976 SEP DISC
>A> + 0.005MG/ML;1.5% N21384 001 AUG 30, 1976 SEP NEWA
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CITANEST FORTE
>A> @ ASTRAZENECA 0.005MG/ML;4% N14763 008 JUN 29, 1970 SEP DISC
>D> + DENTSPLY PHARM 0.005MG/ML;4% N14763 008 JUN 29, 1970 SEP DISC
>A> + 0.005MG/ML;4% N21383 001 JUN 29, 1970 SEP NEWA
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; AN,CNBLK EXTRADURAL, AN,PERIPHERAL NBLK
XYLOCAINE W/ EPINEPHRINE
>A> DENTSPLY PHARM 0.02MG/ML;2% N21381 002 NOV 19, 1948 SEP NEWA
INJECTABLE; AN,PERIPHERAL NBLK
>A> + DENTSPLY PHARM 0.01MG/ML;2% N21381 001 NOV 19, 1948 SEP NEWA
INJECTABLE; INJECTION
>A> @ ASTRAZENECA 0.01MG/ML;2% N06488 003 NOV 19, 1948 SEP DISC
>D> AP + DENTSPLY PHARM 0.01MG/ML;2% N06488 003 NOV 19, 1948 SEP DISC
ETOPOSIDE
CAPSULE; ORAL
>A> ETOPOSIDE
>A> AB GENPHARM 50MG N75635 001 SEP 19, 2001 SEP NEWA
>A> VEPESID
>D> + BRISTOL 50MG N19557 001 DEC 30, 1986 SEP CFTG
>A> AB + 50MG N19557 001 DEC 30, 1986 SEP CFTG
INJECTABLE; INJECTION
>A> ETOPOSIDE
>D> AP PIERRE FABRE 20MG/ML N74813 001 JUL 09, 1997 SEP WDAG
>A> @ 20MG/ML N74813 001 JUL 09, 1997 SEP WDAG
FAMOTIDINE
TABLET; ORAL
FAMOTIDINE
>A> AB PUREPAC PHARM 20MG N75650 001 SEP 14, 2001 SEP NEWA
>A> AB 40MG N75650 002 SEP 14, 2001 SEP NEWA
FENOFIBRATE
TABLET; ORAL
TRICOR
>A> + ABBOTT 160MG N21203 003 SEP 04, 2001 SEP NEWA
FLUDEOXYGLUCOSE, F-18
INJECTABLE; INJECTION
FLUDEOXYGLUCOSE F 18
>A> + DOWNSTATE CLINCL 4-90mCi/ML N20306 002 SEP 25, 2001 SEP NEWA
FLUTAMIDE
CAPSULE; ORAL
>A> EULEXIN
>D> + SCHERING 125MG N18554 001 JAN 27, 1989 SEP CFTG
>A> AB + 125MG N18554 001 JAN 27, 1989 SEP CFTG
>A> FLUTAMIDE
>A> AB BARR 125MG N75820 001 SEP 18, 2001 SEP NEWA
>A> AB EON 125MG N75818 001 SEP 18, 2001 SEP NEWA
>A> AB TEVA 125MG N75298 001 SEP 18, 2001 SEP NEWA
GENTAMICIN SULFATE
OINTMENT; TOPICAL
GARAMYCIN
>D> @ SCHERING EQ 0.1% BASE N60463 001 MAR 15, 1966 SEP DISC
>A> @ EQ 0.1% BASE N60463 001 MAR 15, 1966 SEP DISC
GENTAMICIN
>D> AT CLAY PARK EQ 0.1% BASE N62351 001 FEB 18, 1982 SEP CTEC
>A> AT + EQ 0.1% BASE N62351 001 FEB 18, 1982 SEP CTEC
GLUTETHIMIDE
TABLET; ORAL
GLUTETHIMIDE
>D> @ CELLTECH PHARMS 500MG N85171 001 DEC 22, 1976 SEP DISC
>A> @ 500MG N85171 001 DEC 22, 1976 SEP DISC
HYDROCORTISONE
CREAM; TOPICAL
DERMACORT
>D> AT MONARCH PHARMS 1% N83011 002 APR 26, 1973 SEP WDAG
>A> @ 1% N83011 002 APR 26, 1973 SEP WDAG
IMIPRAMINE HYDROCHLORIDE
TABLET; ORAL
IMIPRAMINE HCL
>D> AB ROXANE 25MG N83799 002 AUG 05, 1977 SEP DISC
>A> @ 25MG N83799 002 AUG 05, 1977 SEP DISC
>D> AB 50MG N83799 003 AUG 05, 1977 SEP DISC
>A> @ 50MG N83799 003 AUG 05, 1977 SEP DISC
IPRATROPIUM BROMIDE
SOLUTION; INHALATION
IPRATROPIUM BROMIDE
>A> AN NEPHRON 0.02% N75562 001 SEP 27, 2001 SEP NEWA
LACTULOSE
SOLUTION; ORAL, RECTAL
LACTULOSE
>D> AA ROXANE 10GM/15ML N73590 001 MAY 29, 1992 SEP DISC
>A> @ 10GM/15ML N73590 001 MAY 29, 1992 SEP DISC
LIDOCAINE HYDROCHLORIDE
INJECTABLE; AN,CNBLK EXTRADURAL, AN,INFILTRATION, AN,PERIPHERAL NBLK
XYLOCAINE
>A> AP + DENTSPLY PHARM 2% N21380 001 NOV 19, 1948 SEP NEWA
INJECTABLE; INJECTION
>A> @ ASTRAZENECA 2% N06488 002 NOV 19, 1948 SEP DISC
>D> AP + DENTSPLY PHARM 2% N06488 002 NOV 19, 1948 SEP DISC
LITHIUM CARBONATE
CAPSULE; ORAL
LITHIUM CARBONATE
>A> AB ABLE 300MG N76121 001 SEP 27, 2001 SEP NEWA
LOMEFLOXACIN HYDROCHLORIDE
TABLET; ORAL
MAXAQUIN
>D> + SEARLE EQ 400MG BASE N20013 001 FEB 21, 1992 SEP CAHN
>A> + UNIMED PHARMS EQ 400MG BASE N20013 001 FEB 21, 1992 SEP CAHN
LORATADINE
TABLET; ORAL
CLARITIN
>D> + SCHERING 10MG N19658 001 APR 12, 1993 SEP CFTG
>A> AB + 10MG N19658 001 APR 12, 1993 SEP CFTG
MANNITOL
INJECTABLE; INJECTION
MANNITOL 25%
>D> AP ASTRAZENECA 12.5GM/50ML N89240 001 MAY 06, 1987 SEP DISC
>A> @ 12.5GM/50ML N89240 001 MAY 06, 1987 SEP DISC
METHOXAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
VASOXYL
>D> + GLAXO WELLCOME 20MG/ML N06772 001 MAR 28, 1949 SEP WDAG
>A> @ 20MG/ML N06772 001 MAR 28, 1949 SEP WDAG
METOCURINE IODIDE
INJECTABLE; INJECTION
METUBINE IODIDE
>D> + LILLY 2MG/ML N06632 003 FEB 15, 1952 SEP WDAG
>A> @ 2MG/ML N06632 003 FEB 15, 1952 SEP WDAG
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HCL
>D> AP BEDFORD EQ 5MG BASE/ML N75249 001 JUN 23, 2000 SEP DISC
>A> @ EQ 5MG BASE/ML N75249 001 JUN 23, 2000 SEP DISC
>D> AP BEN VENUE EQ 5MG BASE/ML N75455 001 JUN 20, 2000 SEP DISC
>A> @ EQ 5MG BASE/ML N75455 001 JUN 20, 2000 SEP DISC
MORPHINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
ORAMORPH SR
>A> BC ELAN PHARMS 15MG N19977 004 NOV 23, 1994 SEP CAHN
>A> BC 30MG N19977 001 AUG 15, 1991 SEP CAHN
>A> BC 60MG N19977 002 AUG 15, 1991 SEP CAHN
>A> BC 100MG N19977 003 AUG 15, 1991 SEP CAHN
>D> BC ROXANE 15MG N19977 004 NOV 23, 1994 SEP CAHN
>D> BC 30MG N19977 001 AUG 15, 1991 SEP CAHN
>D> BC 60MG N19977 002 AUG 15, 1991 SEP CAHN
>D> BC 100MG N19977 003 AUG 15, 1991 SEP CAHN
NABUMETONE
TABLET; ORAL
NABUMETONE
>A> AB TEVA 750MG N75189 002 SEP 24, 2001 SEP NEWA
NEDOCROMIL SODIUM
AEROSOL, METERED; INHALATION
TILADE
>A> + AVENTIS 1.75MG/INH N19660 001 DEC 30, 1992 SEP CAHN
>D> + AVENTIS PHARMS 1.75MG/INH N19660 001 DEC 30, 1992 SEP CAHN
NOREPINEPHRINE BITARTRATE; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
RAVOCAINE AND NOVOCAIN W/ LEVOPHED
>D> + EASTMAN KODAK EQ 0.033MG BASE/ML;2%;0.4% N08592 003 MAR 11, 1955 SEP WDAG
>A> @ EQ 0.033MG BASE/ML;2%;0.4% N08592 003 MAR 11, 1955 SEP WDAG
OXYCODONE HYDROCHLORIDE
TABLET; ORAL
ROXICODONE
>A> ELAN PHARMS 15MG N21011 001 AUG 31, 2000 SEP CAHN
>A> + 30MG N21011 002 AUG 31, 2000 SEP CAHN
>D> ROXANE 15MG N21011 001 AUG 31, 2000 SEP CAHN
>D> + 30MG N21011 002 AUG 31, 2000 SEP CAHN
PORACTANT ALFA
SUSPENSION; INTRATRACHEAL
CUROSURF
>D> + DEY 80MG/ML N20744 001 NOV 18, 1999 SEP CAIN
>A> + 80MG/ML N20744 001 NOV 18, 1999 SEP CAIN
PRILOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CITANEST PLAIN
>A> @ ASTRAZENECA 4% N14763 007 NOV 18, 1965 SEP DISC
>D> + DENTSPLY PHARM 4% N14763 007 NOV 18, 1965 SEP DISC
>A> + 4% N21382 001 NOV 18, 1965 SEP NEWA
PROPRANOLOL HYDROCHLORIDE
TABLET; ORAL
PROPRANOLOL HCL
>D> @ LEDERLE 40MG N70127 001 JUL 30, 1985 SEP DISC
>A> @ 40MG N70127 001 JUL 30, 1985 SEP DISC
RANITIDINE HYDROCHLORIDE
TABLET; ORAL
RANITIDINE HCL
>D> AB BOEHRINGER INGELHEIM EQ 150MG BASE N74662 001 AUG 29, 1997 SEP DISC
>A> @ EQ 150MG BASE N74662 001 AUG 29, 1997 SEP DISC
>D> AB EQ 300MG BASE N74662 002 AUG 29, 1997 SEP DISC
>A> @ EQ 300MG BASE N74662 002 AUG 29, 1997 SEP DISC
SULFACETAMIDE SODIUM
SOLUTION/DROPS; OPHTHALMIC
SULF-10
>D> AT NOVARTIS 10% N80025 001 JUN 03, 1971 SEP CMFD
>A> AT 10% N80025 001 JUN 03, 1971 SEP CMFD
SULFAMETHOXAZOLE; TRIMETHOPRIM
TABLET; ORAL
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
>D> AB ROXANE 800MG;160MG N72769 001 AUG 30, 1991 SEP DISC
>A> @ 800MG;160MG N72769 001 AUG 30, 1991 SEP DISC
TECHNETIUM TC-99M PENTETATE KIT
INJECTABLE; INJECTION
MPI DTPA KIT - CHELATE
>D> AP NYCOMED AMERSHAM N/A N17255 001 APR 15, 1976 SEP WDAG
>A> @ N/A N17255 001 APR 15, 1976 SEP WDAG
THIOTEPA
INJECTABLE; INJECTION
THIOTEPA
>A> AP AAIPHARMA 15MG/VIAL N75698 001 SEP 20, 2001 SEP NEWA
TOBRAMYCIN
SOLUTION; INHALATION
TOBI
>D> + CHIRON 300MG/5ML N50753 001 DEC 22, 1997 SEP CAHN
>A> + 300MG/5ML N50753 001 DEC 22, 1997 SEP CAHN
SOLUTION/DROPS; OPHTHALMIC
TOBRAMYCIN
>A> AT ALTANA 0.3% N65026 001 SEP 11, 2001 SEP NEWA
TRIAMCINOLONE ACETONIDE
AEROSOL, METERED; INHALATION
AZMACORT
>A> + AVENTIS 0.1MG/INH N18117 001 APR 23, 1982 SEP CAHN
>D> + AVENTIS PHARMS 0.1MG/INH N18117 001 APR 23, 1982 SEP CAHN
AEROSOL, METERED; NASAL
NASACORT
>A> + AVENTIS 0.055MG/INH N19798 001 JUL 11, 1991 SEP CAHN
>D> + AVENTIS PHARMS 0.055MG/INH N19798 001 JUL 11, 1991 SEP CAHN
SPRAY, METERED; NASAL
NASACORT AQ
>A> + AVENTIS 0.055MG/SPRAY N20468 001 MAY 20, 1996 SEP CAHN
>D> + AVENTIS PHARMS 0.055MG/SPRAY N20468 001 MAY 20, 1996 SEP CAHN
TRIPTORELIN PAMOATE
INJECTABLE; INTRAMUSCULAR
TRELSTAR
>D> + DEBIO RECHERCHE 11.25MG/VIAL N21288 001 JUN 29, 2001 SEP CAHN
>A> + PHARMACIA AND UPJOHN 11.25MG/VIAL N21288 001 JUN 29, 2001 SEP CAHN
>D> + DEBIO RECHERCHE EQ 3.75MG BASE/VIAL N20715 001 JUN 15, 2000 SEP CAHN
>A> + PHARMACIA AND UPJOHN EQ 3.75MG BASE/VIAL N20715 001 JUN 15, 2000 SEP CAHN
TUBOCURARINE CHLORIDE
INJECTABLE; INJECTION
TUBOCURARINE CHLORIDE
>D> AP + LILLY 3MG/ML N06325 001 NOV 28, 1947 SEP WDAG
>A> @ 3MG/ML N06325 001 NOV 28, 1947 SEP WDAG
VECURONIUM BROMIDE
INJECTABLE; INJECTION
VECURONIUM BROMIDE
>A> + ABBOTT 4MG/VIAL N75558 001 SEP 11, 2001 SEP NEWA
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION)
ZOMETA
>A> + NOVARTIS EQ 4MG BASE/VIAL N21223 001 AUG 20, 2001 SEP CPOT
>D> + EQ 4MG BASE/VIAL N21223 001 AUG 20, 2001 SEP CPOT
ACETAMINOPHEN
SUPPOSITORY; RECTAL
ACETAMINOPHEN
>D> ABLE 120MG N73106 001 FEB 27, 1995 SEP WDAG
>A> @ 120MG N73106 001 FEB 27, 1995 SEP WDAG
>D> 325MG N73107 001 FEB 27, 1995 SEP WDAG
>A> @ 325MG N73107 001 FEB 27, 1995 SEP WDAG
>D> 650MG N73108 001 FEB 27, 1995 SEP WDAG
>A> @ 650MG N73108 001 FEB 27, 1995 SEP WDAG
INSULIN RECOMBINANT PURIFIED HUMAN
INJECTABLE; INJECTION
VELOSULIN BR HUMAN
>D> + NOVO NORDISK 100 UNITS/ML N19450 001 MAY 30, 1986 SEP WDAG
>A> @ 100 UNITS/ML N19450 001 MAY 30, 1986 SEP WDAG
Last update: July 15, 2005 |
|
